AU2002232755A1 - Felodipine transdermal device and methods - Google Patents

Felodipine transdermal device and methods

Info

Publication number
AU2002232755A1
AU2002232755A1 AU2002232755A AU3275502A AU2002232755A1 AU 2002232755 A1 AU2002232755 A1 AU 2002232755A1 AU 2002232755 A AU2002232755 A AU 2002232755A AU 3275502 A AU3275502 A AU 3275502A AU 2002232755 A1 AU2002232755 A1 AU 2002232755A1
Authority
AU
Australia
Prior art keywords
felodipine
methods
transdermal device
skin
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002232755A
Other languages
English (en)
Inventor
Mark Alfonso
Geraldine Marcenyac
Ihor Shevchuk
Lino Tavares
Kirti H. Valia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of AU2002232755A1 publication Critical patent/AU2002232755A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2002232755A 2000-10-23 2001-10-23 Felodipine transdermal device and methods Abandoned AU2002232755A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24251400P 2000-10-23 2000-10-23
US60/242,514 2000-10-23
PCT/US2001/049950 WO2002034206A2 (en) 2000-10-23 2001-10-23 Felodipine transdermal device and methods

Publications (1)

Publication Number Publication Date
AU2002232755A1 true AU2002232755A1 (en) 2002-05-06

Family

ID=22915068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002232755A Abandoned AU2002232755A1 (en) 2000-10-23 2001-10-23 Felodipine transdermal device and methods

Country Status (9)

Country Link
EP (1) EP1328273B1 (de)
AT (1) ATE399551T1 (de)
AU (1) AU2002232755A1 (de)
CY (1) CY1108368T1 (de)
DE (1) DE60134656D1 (de)
DK (1) DK1328273T3 (de)
ES (1) ES2309107T3 (de)
PT (1) PT1328273E (de)
WO (1) WO2002034206A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10305137A1 (de) * 2003-02-07 2004-08-26 Novosis Ag Transdermale therapeutische Abgabesysteme mit einem Butenolid
CA2552887A1 (en) * 2004-01-14 2005-07-28 Lavipharm Laboratories, Inc. Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010781A1 (en) * 1991-12-02 1993-06-10 Sepracor, Inc. Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
US5882676A (en) * 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
WO2000045798A1 (en) * 1999-02-02 2000-08-10 Ortho-Mcneil Pharmaceutical, Inc. Method of manufacture for transdermal matrices

Also Published As

Publication number Publication date
ATE399551T1 (de) 2008-07-15
PT1328273E (pt) 2008-09-23
ES2309107T3 (es) 2008-12-16
DE60134656D1 (de) 2008-08-14
WO2002034206A9 (en) 2003-04-17
WO2002034206A2 (en) 2002-05-02
EP1328273A4 (de) 2004-09-22
EP1328273A2 (de) 2003-07-23
CY1108368T1 (el) 2014-02-12
EP1328273B1 (de) 2008-07-02
WO2002034206A3 (en) 2002-07-18
DK1328273T3 (da) 2008-10-20

Similar Documents

Publication Publication Date Title
AU5876596A (en) Oral dosage and method for treating painful conditions of th e oral cavity
CA2314326A1 (en) Transdermal therapeutic device and method with capsaicin and capsaicin analogs
EP2158907A3 (de) topische Arginin-Verabreichung zur Schmerzbehandlung
AU2001253038A1 (en) Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
GB0001309D0 (en) Valve arrangement
WO2003020202A3 (en) Method for reducing hypertension and heart failure
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
AU1865100A (en) Hyaluronate lyase used for promoting penetration in topical agents
GEP20063828B (en) Methods for Treating or Preventing Skin Disorders Using CD2-Binding Agents
BR9609041A (pt) "terapia de substituição para cáries dentais".
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
CA2322878A1 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
EP1093816A3 (de) Verwendung von ST1435 in Hormonaltherapie durch transdermale Verabreichung
AU2002232755A1 (en) Felodipine transdermal device and methods
WO2002054996A3 (en) Terazosin transdermal device and methods
PT1063978E (pt) Metodo de tratamento de dor de neuroma
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
AU1564500A (en) Method for obtaining and using a combination of a purine and a nitrogen monoxidedonor for preventing or treating sexual dysfunction
TNSN03022A1 (en) Method for treatment of inflammation
UA28769A (uk) Спосіб лікування променевих ушкоджень шкіри
MX9701527A (es) Procedimiento de reducir daños a tejidos asociadoscon isquemia.